Home › FDA approves Genentech drug for advanced lung cancer
 

Keywords :   


FDA approves Genentech drug for advanced lung cancer

2015-12-11 23:03:49| Biotech - Topix.net

The Food and Drug Administration on Friday conditionally approved an experimental Genentech drug for patients with a certain type of lung cancer who have few other options. Alecensa won accelerated approval for patients with advanced non-small cell lung cancer with a mutation in a gene called ALK who have relapsed after treatment with Pfizer Inc.'s Xalkori or who could not tolerate that drug.

Tags: advanced drug cancer lung

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Wind Speed Probabilities Number 22
08.11Hurricane Rafael Forecast Advisory Number 22
08.11Hurricane Rafael Public Advisory Number 22
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11Trump tariffs could cost UK 22bn of exports
08.11Watchdog to review police handling of Al Fayed abuse claims
08.11Cattle marketing: Its about making the right decisions
More »